VivoSeq
Other

Ovulation Induction

0

Pipeline Programs↗

4

Active Trials↗

2

Companies Involved↗

Ovulation Induction is an early-stage landscape with 0 programs across 2 companies. The most active players are Merck & Co., EMD Serono.

Intelligence

Pipeline Metrics

Competitive Density

16/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

81/100

Attrition Rate

13/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Merck & Co. logo

Merck & Co.

0 programs

PreclinicalEMD Serono logo

EMD Serono

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

40

clinical trials

Completed21 · 53%
Unknown status10 · 25%
Recruiting4 · 10%
Withdrawn3 · 8%
Terminated2 · 5%

Clinical Trials

Trial Activity

40 trials

Cabergoline & Letrozole Versus Letrozole in Ovulation Induction in PCOS
Recruiting·—·N/A·NCT07255911·72 enrolled
Letrozole Extended vs Traditional Therapy for Ovulation Induction in Women With PCOS (PROLEx-PCOS)
Recruiting·GGABRIEL MONTEIRO PINHEIRO·N/A·NCT07159880·20 enrolled
Comparison of Clomid and Lezra With Lezra for Ovulation Induction in Clomid Resistant PCOS Case
Recruiting·HHITEC-Institute of Medical Sciences·Phase 1·NCT06813118·42 enrolled
Investigating the Efficiency of Autologous Platelet Rich Plasma Intraovarian Infusion on Improving Ovarian Functionality in Poor Ovarian Response Patients
Recruiting·GGenesis Athens Clinic·Preclinical·NCT05181748·100 enrolled
Ovulation Induction in Women With Clomiphene Citrate Resistant PCOS
Completed·—·Phase 1·NCT01909141·100 enrolled
SJ-0021 (Gonalef®) Versus Purified Pituitary Gonadotropin (Fertinorm-P®) for Ovulation Induction in Japanese Infertile Women
Completed·Merck & Co. logoMerck & Co.·Phase 3·NCT01185782·300 enrolled
Use of Low Dose of HCG During Ovulation Induction With CC in Women With CC Resistant PCOS
Completed·—·Phase 4·NCT02436226·300 enrolled
Nimodipine to Prevent LH Surge During Ovulation Induction: Blinded Placebo-controlled RCT
Completed·BBoston IVF·N/A·NCT01672801·18 enrolled
Oxytocin Versus Human Chorionic Gonadotropin as Trigger in Ovulation Induction
Completed·—·Phase 3·NCT06725004·60 enrolled
Endometrial Shedding Prior to Ovulation Induction Pilot Study
Completed·SSamuel Lunenfeld Research Institute, Mount Sinai Hospital·Phase 4·NCT02340013·50 enrolled
Ovulation Induction in Clomiphene Citrate Resistant PCO Women
Completed·—·Phase 1·NCT02341703·100 enrolled
An Open Label, Canadian Phase IIIb Study With Ovidrel in Ovulation Induction (OI) and Assisted Reproductive Technique (ART)
Completed·EMD Serono logoEMD Serono·N/A·NCT01152866·3 enrolled
Comparison Between Two Ovulation Induction Therapies and LOD on Clinical Outcomes in CC-Resistant PCOS Women
Completed·—·Phase 3·NCT06486870·183 enrolled
Administration of Single High Dose Letrozole for Ovulation Induction
Completed·MMount Sinai Hospital, Canada·Phase 4·NCT02703649·36 enrolled
Comparison of Clomiphene Citrate and Gonadotropins in Ovulation Induction Cycles
Completed·UUniversitair Ziekenhuis Brussel·Phase 4·NCT00835744·40 enrolled
Page 1 of 3

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)